<VariationArchive RecordType="classified" VariationID="1047975" VariationName="NM_000094.4(COL7A1):c.1758del (p.Ser587fs)" VariationType="Deletion" Accession="VCV001047975" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-06-05" DateCreated="2021-03-28" MostRecentSubmission="2022-05-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1035853" VariationID="1047975">
      <GeneList>
        <Gene Symbol="COL7A1" FullName="collagen type VII alpha 1 chain" GeneID="1294" HGNC_ID="HGNC:2214" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48564073" stop="48595329" display_start="48564073" display_stop="48595329" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48601505" stop="48632592" display_start="48601505" display_stop="48632592" Strand="-" />
          </Location>
          <OMIM>120120</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000094.4(COL7A1):c.1758del (p.Ser587fs)</Name>
      <CanonicalSPDI>NC_000003.12:48590694:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48590695" stop="48590695" display_start="48590695" display_stop="48590695" variantLength="1" positionVCF="48590694" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48628128" stop="48628128" display_start="48628128" display_stop="48628128" variantLength="1" positionVCF="48628127" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>S587fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_286" sequenceAccession="LRG_286">
            <Expression>LRG_286:g.9558del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.4" sequenceAccession="NM_000094" sequenceVersion="4" change="c.1758delC" MANESelect="true">
            <Expression>NM_000094.4:c.1758delC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48628129del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48628129del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48590696del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48590696del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007065.1" sequenceAccession="NG_007065" sequenceVersion="1" change="g.9558del">
            <Expression>NG_007065.1:g.9558del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.4" sequenceAccession="NM_000094" sequenceVersion="4" change="c.1758del" MANESelect="true">
            <Expression>NM_000094.4:c.1758del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000085.1" sequenceAccession="NP_000085" sequenceVersion="1" change="p.Ser587fs">
            <Expression>NP_000085.1:p.Ser587fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2045631974" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000094.4(COL7A1):c.1758del (p.Ser587fs) AND Epidermolysis bullosa dystrophica" Accession="RCV001352755" Version="1">
        <ClassifiedConditionList TraitSetID="8897">
          <ClassifiedCondition DB="MedGen" ID="C0079294">Epidermolysis bullosa dystrophica</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-02-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.1758del (p.Ser587fs) AND Transient bullous dermolysis of the newborn" Accession="RCV002246333" Version="1">
        <ClassifiedConditionList TraitSetID="5734">
          <ClassifiedCondition DB="MedGen" ID="C1851573">Transient bullous dermolysis of the newborn</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-04" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-03-28" MostRecentSubmission="2022-05-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5734" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4289" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, NEONATAL</ElementValue>
                <XRef Type="MIM" ID="131705" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, NEONATAL FORM</ElementValue>
                <XRef Type="MIM" ID="131705" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Transient bullous dermolysis of the newborn</ElementValue>
                <XRef ID="Transient+bullous+dermolysis+of+the+newborn/7164" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007548" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa dystrophica, dominant neonatal form</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TBDN</ElementValue>
                <XRef Type="MIM" ID="131705" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10010" />
                <XRef ID="10010" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79411" DB="Orphanet" />
              <XRef ID="C1851573" DB="MedGen" />
              <XRef ID="MONDO:0007548" DB="MONDO" />
              <XRef Type="MIM" ID="131705" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8897" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9485" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa dystrophica</ElementValue>
                <XRef ID="MONDO:0006543" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystrophic epidermolysis bullosa, Hallopeau-Siemens type (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Dystrophic+Epidermolysis+Bullosa/2423" DB="Genetic Alliance" />
                <XRef ID="254185007" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2150" />
                <XRef ID="2150" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="303" DB="Orphanet" />
              <XRef ID="C0079294" DB="MedGen" />
              <XRef ID="MONDO:0006543" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3046809" SubmissionDate="2021-03-10" DateLastUpdated="2021-03-28" DateCreated="2021-03-28">
        <ClinVarSubmissionID localKey="NM_000094.4:c.1758delC|Dystrophic epidermolysis bullosa" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001547288" DateUpdated="2021-03-28" DateCreated="2021-03-28" Type="SCV" Version="1" SubmitterName="Biomedical Innovation Departament, CIEMAT" OrgID="506581" OrganizationCategory="resource" OrgAbbreviation="BioINN" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-02-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Ser587Valfs*28</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.4:c.1758delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Dystrophic epidermolysis bullosa</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9245631</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4932753" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000003.12:g.48590695_48590695delG|OMIM:131705" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002519421" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.12:g.48590695_48590695delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="131705" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4932753" TraitType="Disease" MappingType="XRef" MappingValue="131705" MappingRef="OMIM">
        <MedGen CUI="C1851573" Name="Transient bullous dermolysis of the newborn" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3046809" TraitType="Disease" MappingType="Name" MappingValue="Dystrophic epidermolysis bullosa" MappingRef="Preferred">
        <MedGen CUI="C0079294" Name="Epidermolysis bullosa dystrophica" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

